Clinical Trial Update: Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for REGN475 in pain due to osteoarthritis of the knee or hip, spanning Phase 2 and Phase 3, with the study status reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Knee

Drugs mentioned

• REGN475 (REGN475)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip | Phase 2, Phase 3 | Status: COMPLETED